Your browser doesn't support javascript.
loading
Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study.
Gallicchio, Lisa; Elena, Joanne W; Fagan, Sarah; Carter, Marjorie; Hamilton, Ann S; Hastert, Theresa A; Hunter, Lisa L; Li, Jie; Lynch, Charles F; Milam, Joel; Millar, Morgan M; Modjeski, Denise; Paddock, Lisa E; Reed, Amanda R; Moses, Lisa B; Stroup, Antoinette M; Sweeney, Carol; Trapido, Edward J; West, Michele M; Wu, Xiao-Cheng; Helzlsouer, Kathy J.
Afiliação
  • Gallicchio L; Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland. lisa.gallicchio@nih.gov.
  • Elena JW; Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
  • Fagan S; Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
  • Carter M; Utah Cancer Registry, University of Utah, Salt Lake City, Utah.
  • Hamilton AS; Department of Preventive Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, California.
  • Hastert TA; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Hunter LL; Population Studies and Disparities Research Program, Karmanos Cancer Institute, Detroit, Michigan.
  • Li J; Iowa Cancer Registry, University of Iowa College of Public Health, Iowa City, Iowa.
  • Lynch CF; New Jersey State Cancer Registry, State of New Jersey, Department of Health, Trenton, New Jersey.
  • Milam J; Iowa Cancer Registry, University of Iowa College of Public Health, Iowa City, Iowa.
  • Millar MM; Department of Epidemiology, University of Iowa College of Public Health, Iowa City, Iowa.
  • Modjeski D; Cancer Epidemiology and Population Science Program, Holden Comprehensive Cancer Center, Iowa City, Iowa.
  • Paddock LE; Department of Preventive Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, California.
  • Reed AR; Utah Cancer Registry, University of Utah, Salt Lake City, Utah.
  • Moses LB; Department of Internal Medicine, University of Utah, Salt Lake City, Utah.
  • Stroup AM; Department of Preventive Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, California.
  • Sweeney C; New Jersey State Cancer Registry, State of New Jersey, Department of Health, Trenton, New Jersey.
  • Trapido EJ; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey.
  • West MM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
  • Wu XC; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Helzlsouer KJ; Population Studies and Disparities Research Program, Karmanos Cancer Institute, Detroit, Michigan.
Cancer Epidemiol Biomarkers Prev ; 29(9): 1699-1709, 2020 09.
Article em En | MEDLINE | ID: mdl-32651214
ABSTRACT

BACKGROUND:

While the primary role of central cancer registries in the United States is to provide vital information needed for cancer surveillance and control, these registries can also be leveraged for population-based epidemiologic studies of cancer survivors. This study was undertaken to assess the feasibility of using the NCI's Surveillance, Epidemiology, and End Results (SEER) Program registries to rapidly identify, recruit, and enroll individuals for survivor research studies and to assess their willingness to engage in a variety of research activities.

METHODS:

In 2016 and 2017, six SEER registries recruited both recently diagnosed and longer-term survivors with early age-onset multiple myeloma or colorectal, breast, prostate, or ovarian cancer. Potential participants were asked to complete a survey, providing data on demographics, health, and their willingness to participate in various aspects of research studies.

RESULTS:

Response rates across the registries ranged from 24.9% to 46.9%, with sample sizes of 115 to 239 enrolled by each registry over a 12- to 18-month period. Among the 992 total respondents, 90% answered that they would be willing to fill out a survey for a future research study, 91% reported that they would donate a biospecimen of some type, and approximately 82% reported that they would consent to have their medical records accessed for research.

CONCLUSIONS:

This study demonstrated the feasibility of leveraging SEER registries to recruit a geographically and racially diverse group of cancer survivors. IMPACT Central cancer registries are a source of high-quality data that can be utilized to conduct population-based cancer survivor studies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema de Registros / Programa de SEER / Sobreviventes de Câncer Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema de Registros / Programa de SEER / Sobreviventes de Câncer Idioma: En Ano de publicação: 2020 Tipo de documento: Article